Robert Cohen Email & Phone Number

Andover, Ma, Us

Root, Switzerland, Ch

⬧ Collected feedback from internal and external stakeholders and created comprehensive user needs, strategic intent, and scope for a multi-year next-generation Optune system project intended to overhaul all aspects of the current system.⬧ Researched, consolidated, and prioritized needs, and developed a two-year Agile product roadmap for, OneTouch, Novocure’s internal patient/data management system, including technical and business requirements, epics, themes, user stories, and features.⬧ Led all product management activities for the MyLink data upload system, a cellular-enabled tabletop device used by the patient to transmit data from their Optune device to Novocure.⬧ Updated all product management SOPs and templates for sustainability, clarity, and to allow product management to drive product development through better communication of customer and business needs.⬧ Created new product management templates and processes to streamline and improve effectiveness of communication between product management and other functions, including a new product roadmap template, launch team preparation presentation and checklist, user needs collection template, technical claims matrix, and target product profile.⬧ Coordinated with global patient support, regulatory, quality, and fulfillment centers to develop a new procedure to stock and support patients traveling internationally with essential local equipment.⬧ Represented the product development function in identifying, proposing, and defining technical and business requirements for collaborations with Enterprise Technology on robotic process automations designed to increase efficiency and improve patient data fidelity.

Amsterdam, Noord-Holland, Nl

⬧ Supervised a three-person team of product managers with open requisitions for an additional three. Provided additional indirect management for all team activities related to General Care monitoring in interim role while overall General Care lead position was open.⬧ Coordinated strategic portfolio development initiatives with other product groups within Enterprise Hospital Monitoring, Clinical Applications & Devices, and Clinical Data Services.⬧ Directly managed three products within the monitoring portfolio: legacy MP5SC; pre-commercial Evoline SC premium spot check monitor; and Vitals Plus integrated continuous monitor.⬧ Designed, aligned, and implemented a quarterly General Care Roadmap report to standardize communication with global Markets through Business Development Managers, Business Market Managers, and Country Leads.⬧ Led all BMC Enablement activities for General Care, including current enablers focused on accelerating roadmap development, streamlining order fulfillment, and implementing alternative sales channels (e.g. e-commerce) to encourage sales growth.⬧ Represented the business from both sides of the acquisition in the integration of the Capsule commercial catalog into Philips systems and Ways of Working.⬧ Defined long-term strategic vision for General Care monitoring portfolio including product improvements and MVP features and functionality for next-generation solution.

Amsterdam, Noord-Holland, Nl

⬧ Managed the hardware portfolio to 106% quota achievement in 2021 in a year where Capsule as a whole ended the year at 83%.⬧ Prioritized the roadmap for the Capsule hardware portfolio, including the management of new features and enhancements such as a Network Connectivity Module, UI improvements, simplified workflow through rapid badge authentication, and more.⬧ Proactively presented a plan to the C-suite in Q1 2021 to increase investment in the hardware roadmap to accelerate a significant hardware revision to the Neuron 3, resulting in new components or supply chain sources for nine key components, enabling the Neuron to be sold without price increase and with no backlog or interruption in availability through global supply chain shortages.⬧ Promoted a focus on international sales including dedicated product training, new pricing models, and development of distributor relationships, contributing to a 367% increase in Y-Y Neuron sales from 2020 to 2021.⬧ Coordinated all commercial activities for integration of Capsule into Philips, including catalog ownership, product transfer between business units to promote strategic alignment, template validation sessions, and development of new Ways of Working.⬧ Owned all direct and partner updates to the Capsule Commercial Pricing Policy and the Global Price Book, including hardware, software, subscriptions, and services.⬧ Authored a series of published articles on edge computing in a healthcare environment, cybersecurity, and other key topics facing hospitals today.⬧ Drove a strategic sales and development focus on accessories for add-on and recurring revenue.⬧ Received an overall Exceeds rating for the 2021 fiscal year, including a Top rating for communication.

Lexington, Ma, Us

⬧ Created and implemented a series of changes to the product manufacturing process to reduce COGS by over 30%, as well as a manufacturing demand forecast tool used to set the Galatea Manufacturing Schedule.⬧ Developed and implemented a Sales Management Dashboard to serve as a CRM tool for the Commercial team and coordinated a manual monthly sales closeout process with Galatea Sales, Logistics, and CFO.⬧ Created and ran a monthly International S&OP meeting that included Sales, Marketing, Logistics, Manufacturing, Quality, Regulatory, and Engineering.⬧ Designed a demo sample to reduce product sample costs by 75%.⬧ Led strategic planning and forecasting efforts for the Commercial organization related to the COVID-19 pandemic.⬧ Researched and drafted a strategic Sales territory alignment and hiring plan adopted by Galatea leadership.⬧ Proposed and coordinated a shelf life study that led to extension from two years to up to four years for Galatea products.⬧ Opened a Change Control for an extended shipping validation to increase acceptable ship time from 72-hours to 144-hours, allowing both for international shipments and the establishment of a formal returns process.⬧ Created an initial proposal and coordinated the creation of 2020 quota and compensation plan for the Sales team; designed and ran an annual Sales Contest incorporating Y-Y growth, % to Plan, Account Addition and Volume, and ASP.⬧ Researched and led a plan to reduce the number of available SKUs offered by Galatea to eliminate products with low sales volume to increase Operations efficiency in preparation for new product launches.

Us

Held primary product management responsibility for a product line (HeartLight) that more than doubledin revenue during my time with the Company; managed the US launch of the Excalibur Balloon Ablation Catheter, coordinating the efforts of Sales, Marketing, Training, Field Service, Customer Support, Supply Chain, and Manufacturing and presenting the Board of Directors with a detailed competitive assessment that led to an acceleration of the launch timeline; due to organizational deficiencies, executed strategic tasks including a reorganization of the EU sales team, creation of research and competition-driventarget lists, and development of a NEW Hire Kit which led to a 50% reduction in time to field certification for new sales reps; wrote and launched a new CardioFocus Quarterly Update through Mailchimp to all Company subscribers, which achieved a 40% higher open rate than the industry average for Mailchimp and a 25% higher click rate for links.

Danvers, Ma, Us

Managed a product family (Impella) with 35% year-over-year revenue growth ($330M to $445M)with an additional growth of $150M in the following year due in part to two product launches I planned, the Impella Connect remote device/patient management system and the Impella 5.5; researched and developed market models for cardiogenic shock and chronic heart failure leading to an adjustment of investor guidance and reprioritization of strategic roadmap; provided population analyticsand recruitment estimates for proposed Randomized Controlled Trials ranging in investment from $15M-$70M, leading to the selection of several specific studies and the exclusion of a previously planned $70M study due to identified enrollment issues and smaller-than-anticipated patient benefit.

Ma, 01824, Us

Managed a product (LifeVest) with annual growth >30% during my tenure, resulting in overall revenueof over $600M in my final year; coordinated strategic team efforts for the creation of ZOLL LifeVest's first new business unit, ZOLL Diagnostics, and the launch of a new cardiac monitor product and acquisition of a heart failure diagnostics company; designed an updated order fulfillment process that included an e-Ordering mobile app that reduced denials by 60% and tripled same quarter year-to-year e-Orders; led investigations into new markets including military, in-hospital, and sleep apnea, resulting in the development of the Hospital Wearable Defibrillator for in-hospital use.

Worked in all areas detailed in the Company description as part of a full market assessment project including creating the framework and completing a high-level landscape for a client looking at a new technology; led meetings with clients ranging from Product Managers to CEOs; performed initial research, synthesis, and modeling for a disease state research report; represented the Company at industry events such as the annual LifeScience Alley Conference; conducted physician interviews as a primary supplement to secondary research on client projects.

Boston, Ma, Us

Modeled a forecast of market size for potential markets for Haemonetics products including drafting amarket/product survey on potential markets (Interventional Cardiology and Stroke Management) administered to key opinion leaders in the field and created presentations from original research provided to immediate superiors and the Board of Directors on topics including major competitors and potential strategic partners.

B.A., English

High School